Increasing the visibility of tissue viability nurses
Research led by Dr Fania Pagnamenta, nurse consultant/associate professor and professional lead for tissue viability at Newcastle Hospitals and Northumbria University, has highlighted the challenges faced by lead tissue viability nurses (LTVns) in exercising influence within healthcare organisations.
Published in Nursing Open, the qualitative study drew on interviews with experienced LTVNs from some of England’s largest NHS teaching and research trusts to explore how agency, autonomy and authority shape their ability to lead wound care services and improve patient outcomes.
The research addresses a longstanding challenge within healthcare systems: while LTVNs are recognised as advanced practitioners with responsibility for complex clinical decision-making, policy development and quality improvement, their expertise is not always matched by organisational influence.
The findings call for greater recognition of the role and the specialist knowledge these nurses bring to improving wound care outcomes, patient safety and the effective use of healthcare resources.
What are lead tissue viability nurses?
LTVNs are highly specialised registered nurses who provide professional leadership for tissue viability services and manage teams of tissue viability nurses working across acute, community and specialist settings.
They are responsible for preventing and managing complex wounds, supporting organisational governance, developing clinical policies, advising on procurement decisions and educating the wider healthcare workforce.
Working across all age groups and clinical specialties, LTVNs deliver expert care with a high degree of clinical autonomy and frequently practise without direct medical supervision. Their role is founded on the four pillars of advanced nursing practice: clinical practice, education, leadership and research.
As a result, they combine specialist clinical expertise with strategic leadership responsibilities that influence care delivery across entire healthcare organisations.
Results
The study found that LTVNs routinely exercise advanced clinical judgement and leadership but often experience limitations in organisational authority and influence.
Participants described a complex role requiring expertise in clinical practice, education, leadership, governance, procurement and research, while simultaneously navigating organisational structures that do not always recognise or fully utilise their specialist knowledge.
The findings highlight a disconnect between the expectations placed upon these senior nurses and the authority afforded to them to fulfil their responsibilities.
The study concludes that clearer professional recognition, stronger organisational support and a more clearly articulated professional identity are needed if LTVNs are to realise their full potential in improving patient outcomes and advancing wound care practice.
An experienced clinical academic
The publication is part of a wider programme of clinical academic activity led by Dr Pagnamenta, focused on improving wound care practice, strengthening the evidence base for clinical decision-making and advancing specialist nursing practice. Her work spans research, innovation, workforce development and service improvement, ensuring that evidence generated through research translates directly into benefits for patients and healthcare services.
Over the past five years, Dr Pagnamenta has led and contributed to a range of projects examining clinical innovation, professional education, healthcare communication and wound care technologies.
Her research reflects a commitment to addressing practical challenges faced by clinicians while generating evidence that can influence policy, practice and professional development.
The development of single-use tenatome
Dr Pagnamenta led a study evaluating the effectiveness of a single-use tenotome in preparing the skin for compression therapy in patients with chronic leg ulceration. The research informed the development of an innovative clinical product that subsequently became commercially available within the UK, demonstrating how clinician-led research can directly contribute to service innovation and patient care.
Cinnamon study
Dr Pagnamenta is currently leading an observational study evaluating a novel cinnamon-based dressing designed to reduce malodour associated with fungating tumours. The study aims to improve quality of life for patients experiencing one of the most distressing symptoms associated with advanced disease and continues until 2028.
Additional clinical academic work has included a training needs analysis exploring nurses’ knowledge, confidence and educational aspirations in wound care, as well as research examining how leg ulceration is represented in the UK print media. Together, these studies demonstrate a broad programme of work focused on improving wound care through clinical innovation, workforce development, public engagement and evidence-informed practice.
ROSE study
Dr Pagnamenta is currently leading the ROSE Study, a realist evaluation investigating how clinicians select compression bandages for people with lower limb ulceration. Although compression therapy is recognised as the gold standard treatment for venous leg ulcers, there is limited evidence to guide the selection of different compression systems for individual patients.
The study is exploring how patient needs, clinician experience and healthcare contexts influence treatment choices, with the aim of developing practical guidance to support personalised compression therapy. The findings will contribute to improving care for people living with leg ulcers, a condition that has a significant impact on quality of life and places considerable demands on healthcare services.
Speaking about her clinical academic career, Dr Pagnamenta said:
“My clinical academic career has given me the opportunity to carry out research that makes a real difference locally and nationally. This dual role has allowed me to continue my clinical career while contributing to vital research. I would recommend anyone with a keen interest in research to consider a clinical academic position.”
About Dr Fania Pagnamenta
Fania has more than 35 years of nursing experience and over 24 years’ experience as a nurse consultant. She combines senior clinical leadership with an active research portfolio, enabling her to bridge the gap between research, policy and frontline practice.
As professional lead for tissue viability at Newcastle Hospitals, she is responsible for shaping clinical strategy, developing policies and standards, supporting professional development and driving innovation in wound care. Her leadership has contributed to workforce capability, service improvement and the advancement of specialist nursing practice across both hospital and community settings.
Throughout her career, Fania has remained committed to improving outcomes for patients with wounds while championing the role of specialist nurses. Her clinical academic work continues to generate new knowledge, challenge established assumptions and strengthen the evidence underpinning wound care practice locally, nationally and internationally.